Gut microbial-derived 3,4-dihydroxyphenylacetic acid ameliorates reproductive phenotype of polycystic ovary syndrome

Abstract

Polycystic ovary syndrome (PCOS) is a prevalent endocrine and reproductive disorder affecting women of reproductive age. While the gut microbiota has been implicated in PCOS pathophysiology, the role of microbial-derived metabolites as mediators of host–microbe interactions remains poorly defined. Here, we integrated untargeted gut metabolomics with metagenomic profiling in patients with PCOS and identified a marked depletion of 3,4-dihydroxyphenylacetic acid (DHPAA), a flavonoid-derived microbial catabolite. Oral administration of DHPAA ameliorated PCOS-like phenotypes in two mouse models by suppressing bone morphogenetic protein signaling and reducing anti-Müllerian hormone (AMH) levels. We found that DHPAA production depends on gut microbial degradation of dietary flavonoids. We further identified a bacterial species, Streptococcus thermophilus, consistently depleted in PCOS across two human cohorts and a mouse model, restored DHPAA levels and improved reproductive outcomes in mice. Conversely, a β-galactosidase-deficient mutant of S. thermophilus failed to confer these benefits, highlighting β-galactosidase as a critical enzyme in DHPAA biosynthesis. Our findings establish DHPAA as a key microbial metabolite linking diet, microbiota, and reproductive health, and propose its potential as a novel therapeutic candidate for PCOS.

Keywords

3,4-dihydroxyphenylacetic acid / gut metabolome / gut microbiota / polycystic ovary syndrome / Streptococcus thermophilus / β-galactosidase

References

[1] Azziz, Ricardo, Enrico Carmina, ZiJiang Chen, Andrea Dunaif, Joop S. E. Laven, Richard S. Legro, Daria Lizneva, et al. 2016. “Polycystic Ovary Syndrome.” Nature Reviews Disease Primers 2: 16057. https://doi.org/10.1038/nrdp.2016.57

[2] Stener-Victorin, Elisabet, Helena Teede, Robert J. Norman, Richard Legro, Mark O. Goodarzi, Anuja Dokras, Joop Laven, Kathleen Hoeger, and Terhi T. Piltonen. 2024. “Polycystic Ovary Syndrome.” Nature Reviews Disease Primers 10: 27. https://doi.org/10.1038/s41572-024-00511-3

[3] Joham, Anju E., Robert J. Norman, Elisabet Stener-Victorin, Richard S. Legro, Stephen Franks, Lisa J. Moran, Jacqueline Boyle, and Helena J. Teede. 2022. “Polycystic Ovary Syndrome.” Lancet Diabetes & Endocrinology 10: 668-680. https://doi.org/10.1016/s2213-8587(22)00163-2

[4] Wan, Zhengwei, Jianhui Zhao, Yongju Ye, Zhaochen Sun, Kangning Li, Yan Chen, and Yuan Fang, et al. 2024. “Risk and Incidence of Cardiovascular Disease Associated With Polycystic Ovary Syndrome.” European Journal of Preventive Cardiology 31: 1560-1570. https://doi.org/10.1093/eurjpc/zwae066

[5] Escobar-Morreale, Héctor F. 2018. “Polycystic Ovary Syndrome: Definition, Aetiology, Diagnosis and Treatment.” Nature Reviews Endocrinology 14: 270-284. https://doi.org/10.1038/nrendo.2018.24

[6] Torres, Pedro J., Martyna Siakowska, Beata Banaszewska, Leszek Pawelczyk, Antoni J. Duleba, Scott T. Kelley, and Varykina G. Thackray. 2018. “Gut Microbial Diversity in Women With Polycystic Ovary Syndrome Correlates With Hyperandrogenism.” Journal of Clinical Endocrinology & Metabolism 103: 1502-1511. https://doi.org/10.1210/jc.2017-02153

[7] Qi, Xinyu, Chuyu Yun, Lulu Sun, Jialin Xia, Qing Wu, Ying Wang, Lina Wang, et al. 2019. “Gut Microbiota-Bile Acid-Interleukin-22 Axis Orchestrates Polycystic Ovary Syndrome.” Nature Medicine 25: 1225-1233. https://doi.org/10.1038/s41591-019-0509-0

[8] Li, Pan, Ping Shuai, Sj Shen, Huimin Zheng, Ping Sun, Renfang Zhang, Shanwei Lan, et al. 2023. “Perturbations in Gut Microbiota Composition in Patients With Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis.” BMC Medicine 21: 302. https://doi.org/10.1186/s12916-023-02975-8

[9] Yun, Chuyu, Sen Yan, Baoying Liao, Yong Ding, Xinyu Qi, Min Zhao, Kai Wang, et al. 2024. “The Microbial Metabolite Agmatine Acts as an FXR Agonist to Promote Polycystic Ovary Syndrome in Female Mice.” Nature Metabolism 6: 947-962. https://doi.org/10.1038/s42255-024-01041-8

[10] Shoaei, Tanaz, Motahar Heidari-Beni, HatavGhasemi Tehrani, Awat feizi, Ahmad Esmaillzadeh, and Gholamreza Askari. 2015. “Effects of Probiotic Supplementation on Pancreatic β-Cell Function and C-Reactive Protein in Women With Polycystic Ovary Syndrome: A Randomized Double-Blind Placebo-Controlled Clinical Trial.” International Journal of Preventive Medicine 6: 27. https://doi.org/10.4103/2008-7802.153866

[11] Jamilian, Mehri, Shirin Mansury, Fereshteh Bahmani, Zahra Heidar, Elaheh Amirani, and Zatollah Asemi. 2018. “The Effects of Probiotic and Selenium Co-Supplementation on Parameters of Mental Health, Hormonal Profiles, and Biomarkers of Inflammation and Oxidative Stress in Women With Polycystic Ovary Syndrome.” Journal of Ovarian Research 11: 80. https://doi.org/10.1186/s13048-018-0457-1

[12] Chen, Mingyue, Chengyong He, Kongyang Zhu, Zihan Chen, Zixiao Meng, Xiaoming Jiang, Jiali Cai, Chunyan Yang, and Zhenghong Zuo. 2022. “Resveratrol Ameliorates Polycystic Ovary Syndrome via Transzonal Projections Within Oocyte-Granulosa Cell Communication.” Theranostics 12: 782-795. https://doi.org/10.7150/thno.67167

[13] Feng, Xinchi, Yang Li, Mahmood Brobbey Oppong, and Feng Qiu. 2018. “Insights Into the Intestinal Bacterial Metabolism of Flavonoids and the Bioactivities of Their Microbe-Derived Ring Cleavage Metabolites.” Drug Metabolism Reviews 50: 343-356. https://doi.org/10.1080/03602532.2018.1485691

[14] Zheng, Huimin, Feihong Mai, Siyou Zhang, Zixin Lan, Zhang Wang, Shanwei Lan, Renfang Zhang, et al. 2024. “In Silico Method to Maximise the Biological Potential of Understudied Metabolomic Biomarkers: A Study in Pre-Eclampsia.” Gut 73: 383-385. https://doi.org/10.1136/gutjnl-2022-329312

[15] Liu, Yang, Jing-jing Jiang, Shao-yue Du, Liang-shan Mu, Jian-jun Fan, Jun-chi Hu, Yao Ye, et al. 2024. “Artemisinins Ameliorate Polycystic Ovarian Syndrome by Mediating LONP1-CYP11A1 Interaction.” Science 384: eadk5382. https://doi.org/10.1126/science.adk5382

[16] di Clemente, Nathalie, Chrystèle Racine, Alice Pierre, and Joëlle Taieb. 2021. “Anti-Müllerian Hormone in Female Reproduction.” Endocrine Reviews 42: 753-782. https://doi.org/10.1210/endrev/bnab012

[17] Roy, Sambit, Divya Gandra, Christina Seger, Anindita Biswas, Vitaly A. Kushnir, Norbert Gleicher, T. Rajendra Kumar, and Aritro Sen. 2018. “Oocyte-Derived Factors (GDF9 and BMP15) and FSH Regulate AMH Expression via Modulation of H3K27AC in Granulosa Cells.” Endocrinology 159: 3433-3445. https://doi.org/10.1210/en.2018-00609

[18] Zhao, Zhongquan, Fangyue Guo, Xiaowei Sun, Qijie He, Zinuo Dai, Xiaochuan Chen, Yongju Zhao, and Jian Wang. 2018. “BMP15 Regulates AMH Expression via the p38 MAPK Pathway in Granulosa Cells From Goat.” Theriogenology 118: 72-79. https://doi.org/10.1016/j.theriogenology.2018.05.032

[19] Tata, Brooke, Nour El Houda Mimouni, Anne-Laure Barbotin, Samuel A. Malone, Anne Loyens, Pascal Pigny, Didier Dewailly, et al. 2018. “Elevated Prenatal Anti-Müllerian Hormone Reprograms the Fetus and Induces Polycystic Ovary Syndrome in Adulthood.” Nature Medicine 24: 834-846. https://doi.org/10.1038/s41591-018-0035-5

[20] Mimouni, Nour El Houda, Isabel Paiva, Anne-Laure Barbotin, Fatima Ezzahra Timzoura, Damien Plassard, Stephanie Le Gras, Gaetan Ternier, et al. 2021. “Polycystic Ovary Syndrome Is Transmitted via a Transgenerational Epigenetic Process.” Cell Metabolism 33: 513-530.e8. https://doi.org/10.1016/j.cmet.2021.01.004

[21] Dias, Maria Celeste, Diana C. G. A. Pinto, and Artur M. S. Silva. 2021. “Plant Flavonoids: Chemical Characteristics and Biological Activity.” Molecules 26: 5377. https://doi.org/10.3390/molecules26175377

[22] Farha, Arakkaveettil Kabeer, Ren-You Gan, Hua-Bin Li, Ding-Tao Wu, Atanas G. Atanasov, Khalid Gul, Jia-Rong Zhang, Qiong-Qiong Yang, and Harold Corke. 2020. “The Anticancer Potential of the Dietary Polyphenol Rutin: Current Status, Challenges, and Perspectives.” Critical Reviews in Food Science and Nutrition 62: 832-859. https://doi.org/10.1080/10408398.2020.1829541

[23] Catalán, Mabel, Jorge Ferreira, and Catalina Carrasco-Pozo. 2020. “The Microbiota-Derived Metabolite of Quercetin, 3,4-Dihydroxyphenylacetic Acid Prevents Malignant Transformation and Mitochondrial Dysfunction Induced by Hemin in Colon Cancer and Normal Colon Epithelia Cell Lines.” Molecules 25: 4138. https://doi.org/10.3390/molecules25184138

[24] Murota, Kaeko, Yoshimasa Nakamura, and Mariko Uehara. 2018. “Flavonoid Metabolism: The Interaction of Metabolites and Gut Microbiota.” Bioscience, Biotechnology, and Biochemistry 82: 600-610. https://doi.org/10.1080/09168451.2018.1444467

[25] Han, Qixin, Juan Wang, Weiping Li, Zi-Jiang Chen, and Yanzhi Du. 2021. “Androgen-Induced Gut Dysbiosis Disrupts Glucolipid Metabolism and Endocrinal Functions in Polycystic Ovary Syndrome.” Microbiome 9: 101. https://doi.org/10.1186/s40168-021-01046-5

[26] Xie, Shihao, Jiaxin Li, Fengyuan Lyu, Qingming Xiong, Peng Gu, Yuqi Chen, Meiling Chen, et al. 2024. “Novel Tripeptide RKH Derived From Akkermansia muciniphila Protects Against Lethal Sepsis.” Gut 73: 78-91. https://doi.org/10.1136/gutjnl-2023-329996

[27] Cani, Patrice D., Clara Depommier, Muriel Derrien, Amandine Everard, and Willem M. de Vos. 2022. “Akkermansia muciniphila: Paradigm for Next-Generation Beneficial Microorganisms.” Nature Reviews Gastroenterology & Hepatology 19: 625-637. https://doi.org/10.1038/s41575-022-00631-9

[28] Manson McGuire, Abigail, Kyla Cochrane, Allison D. Griggs, Brian J. Haas, Thomas Abeel, Qiandong Zeng, Justin B. Nice, et al. 2014. “Evolution of Invasion in a Diverse Set of Fusobacterium Species.” mBio 5: e01864. https://doi.org/10.1128/mBio.01864-14

[29] He, Yan, Prabhakar Mujagond, Wenli Tang, Wei Wu, Huimin Zheng, Xia Chen, Muxuan Chen, et al. 2021. “Non-Nucleatum Fusobacterium Species Are Dominant in the Southern Chinese Population With Distinctive Correlations to Host Diseases Compared With F. Nucleatum.” Gut 70: 810-812. https://doi.org/10.1136/gutjnl-2020-322090

[30] Gacesa, R., A. Kurilshikov, A. Vich Vila, T. Sinha, M. A. Y. Klaassen, L. A. Bolte, S. Andreu-Sánchez, et al. 2022. “Environmental Factors Shaping the Gut Microbiome in a Dutch Population.” Nature 604: 732-739. https://doi.org/10.1038/s41586-022-04567-7

[31] Gaulke, Christopher A., and Thomas J. Sharpton. 2018. “The Influence of Ethnicity and Geography on Human Gut Microbiome Composition.” Nature Medicine 24: 1495-1496. https://doi.org/10.1038/s41591-018-0210-8

[32] He, Yan, Wei Wu, Hui-Min Zheng, Pan Li, Daniel McDonald, Hua-Fang Sheng, Mu-Xuan Chen, et al. 2018. “Regional Variation Limits Applications of Healthy Gut Microbiome Reference Ranges and Disease Models.” Nature Medicine 24: 1532-1535. https://doi.org/10.1038/s41591-018-0164-x

[33] Thilakarathna, Surangi, and H. Rupasinghe. 2013. “Flavonoid Bioavailability and Attempts for Bioavailability Enhancement.” Nutrients 5: 3367-3387. https://doi.org/10.3390/nu5093367

[34] He, Zhishu, Hao Zhang, Tao Wang, Ren Wang, and Xiaohu Luo. 2022. “Effects of Five Different Lactic Acid Bacteria on Bioactive Components and Volatile Compounds of Oat.” Foods 11: 3230. https://doi.org/10.3390/foods11203230

[35] Bateman, Alex, Maria-Jesus Martin, Sandra Orchard, Michele Magrane, Shadab Ahmad, Emanuele Alpi, Emily H. Bowler-Barnett, et al. 2023. “UniProt: The Universal Protein Knowledgebase in 2023.” Nucleic Acids Research 51: D523-D531. https://doi.org/10.1093/nar/gkac1052

[36] Ozdal, Tugba, David A. Sela, Jianbo Xiao, Dilek Boyacioglu, Fang Chen, and Esra Capanoglu. 2016. “The Reciprocal Interactions Between Polyphenols and Gut Microbiota and Effects on Bioaccessibility.” Nutrients 8: 78. https://doi.org/10.3390/nu8020078

[37] Wu, Jiayu, Kai Wang, Xinyu Qi, Shuang Zhou, Shuyun Zhao, Meisong Lu, Qixing Nie, et al. 2025. “The Intestinal Fungus Aspergillus Tubingensis Promotes Polycystic Ovary Syndrome Through a Secondary Metabolite.” Cell Host & Microbe 33: 119-136.e111. https://doi.org/10.1016/j.chom.2024.12.006

[38] Rajska, Anna, Magdalena Buszewska-Forajta, Dominik Rachoń, and Michał Jan Markuszewski. 2020. “Metabolomic Insight Into Polycystic Ovary Syndrome—An Overview.” International Journal of Molecular Sciences 21: 4853. https://doi.org/10.3390/ijms21144853

[39] Cree-Green, Melanie, Anne-Marie Carreau, Haseeb Rahat, Yesenia Garcia-Reyes, Bryan C. Bergman, Laura Pyle, and Kristen J. Nadeau. 2019. “Amino Acid and Fatty Acid Metabolomic Profile During Fasting and Hyperinsulinemia in Girls With Polycystic Ovarian Syndrome.” American Journal of Physiology-Endocrinology and Metabolism 316: E707-E718. https://doi.org/10.1152/ajpendo.00532.2018

[40] Maleki, Vahid, Amir Hossein Faghfouri, Fatemeh Pourteymour Fard Tabrizi, Jalal Moludi, Sevda Saleh-Ghadimi, Hamed Jafari-Vayghan, and Shaimaa A. Qaisar. 2021. “Mechanistic and Therapeutic Insight Into the Effects of Cinnamon in Polycystic Ovary Syndrome: A Systematic Review.” Journal of Ovarian Research 14: 130. https://doi.org/10.1186/s13048-021-00870-5

[41] Hussain, Liaqat, Noor Aamir, Musaddique Hussain, Muhammad Asif, Zunera Chauhdary, Faiza Manzoor, Rida Siddique, Muhammad Riaz, and Alamgeer Yuchi. 2022. “Therapeutic Investigation of Standardized Aqueous Methanolic Extract of Bitter Melon (Momordica charantia L.) for Its Potential Against Polycystic Ovarian Syndrome in Experimental Animals' Model: In Vitro and In Vivo Studies.” Evidence-Based Complementary and Alternative Medicine 2022: 1-14. https://doi.org/10.1155/2022/5143653

[42] Zhang, Jiacheng, Haolin Zhang, Xiyan Xin, Yutian Zhu, Yang Ye, and Dong Li. 2022. “Efficacy of Flavonoids on Animal Models of Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis.” Nutrients 14: 4128. https://doi.org/10.3390/nu14194128

[43] Mihanfar, Aynaz, Mohammad Nouri, Leila Roshangar, and Mohammad Hassan Khadem-Ansari. 2021. “Polyphenols: Natural Compounds With Promising Potential in Treating Polycystic Ovary Syndrome.” Reproductive Biology 21: 100500. https://doi.org/10.1016/j.repbio.2021.100500

[44] Delgado, Amélia Martins, Manel Issaoui, and Nadia Chammem. 2019. “Analysis of Main and Healthy Phenolic Compounds in Foods.” Journal of AOAC International 102: 1356-1364. https://doi.org/10.5740/jaoacint.19-0128

[45] Palioura, Eleni, and Evanthia Diamanti-Kandarakis. 2016. “Polycystic Ovary Syndrome (PCOS) and Endocrine Disrupting Chemicals (EDCs).” Reviews in Endocrine and Metabolic Disorders 16: 365-371. https://doi.org/10.1007/s11154-016-9326-7

[46] Jahan, Sarwat, Faryal Munir, Suhail Razak, Anam Mehboob, Qurat Ul Ain, Hizb Ullah, Tayyaba Afsar, Ghazala Shaheen, and Ali Almajwal. 2016. “Ameliorative Effects of Rutin Against Metabolic, Biochemical and Hormonal Disturbances in Polycystic Ovary Syndrome in Rats.” Journal of Ovarian Research 9: 86. https://doi.org/10.1186/s13048-016-0295-y

[47] Hu, Tao, Xiaoxue Yuan, Rongcai Ye, Huiqiao Zhou, Jun Lin, Chuanhai Zhang, Hanlin Zhang, et al. 2017. “Brown Adipose Tissue Activation by Rutin Ameliorates Polycystic Ovary Syndrome in Rat.” Journal of Nutritional Biochemistry 47: 21-28. https://doi.org/10.1016/j.jnutbio.2017.04.012

[48] Shi, Chun-Lin, Tong Chen, Canhui Lan, Ren-You Gan, Jun Yu, Fangqing Zhao, and Yong-Xin Liu. 2024. “iMetaOmics: Advancing Human and Environmental Health Through Integrated Meta-Omics.” iMetaOmics 1: 1. https://doi.org/10.1002/imo2.21

[49] Ding, Huafang, Jianhui Liu, Zixing Chen, Shouhe Huang, Chi Yan, Erika Kwek, Zouyan He, Hanyue Zhu, and Zhen-Yu Chen. 2024. “Protocatechuic Acid Alleviates TMAO-Aggravated Atherosclerosis via Mitigating Inflammation, Regulating Lipid Metabolism, and Reshaping Gut Microbiota.” Food & Function 15: 881-893. https://doi.org/10.1039/d3fo04396g

[50] An, Sheng, Yi Yao, Junjie Wu, Hongbin Hu, Jie Wu, Maomao Sun, Jiaxin Li, et al. 2024. “Gut-Derived 4-Hydroxyphenylacetic Acid Attenuates Sepsis-Induced Acute Kidney Injury by Upregulating ARC to Inhibit Necroptosis.” Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1870: 166876. https://doi.org/10.1016/j.bbadis.2023.166876

[51] Gu, Peng, Ruofan Liu, Qin Yang, Li Xie, Rongjuan Wei, Jiaxin Li, Fengyi Mei, et al. 2023. “A Metabolite From Commensal Candida Albicans Enhances the Bactericidal Activity of Macrophages and Protects Against Sepsis.” Cellular & Molecular Immunology 20: 1156-1170. https://doi.org/10.1038/s41423-023-01070-5

[52] Tan, Jijun, Ruizhi Hu, Jiatai Gong, Chengkun Fang, Yanli Li, Ming Liu, Ziyu He, et al. 2023. “Protection Against Metabolic Associated Fatty Liver Disease by Protocatechuic Acid.” Gut Microbes 15: 2238959. https://doi.org/10.1080/19490976.2023.2238959

[53] Yoshino, K., K. Takahashi, Y. Eda, A. Nishigaki, and M. Kitao. 1993. “Peripheral Catecholamine Metabolites and Menstrual Irregularity in Patients With Polycystic Ovaries.” Int Journal of Fertility and Menopausal Studies 38: 225-228. https://www.ncbi.nlm.nih.gov/pubmed/8401681

[54] Han, Nathan D., Jiye Cheng, Omar Delannoy-Bruno, Daniel Webber, Nicolas Terrapon, Bernard Henrissat, Dmitry A. Rodionov, et al. 2022. “Microbial Liberation of N-Methylserotonin From Orange Fiber in Gnotobiotic Mice and Humans.” Cell 185: 2495-2509.e11. https://doi.org/10.1016/j.cell.2022.06.004

[55] Hols, Pascal, Frédéric Hancy, Laetitia Fontaine, Benoît Grossiord, Deborah Prozzi, Nathalie Leblond-Bourget, Bernard Decaris, et al. 2005. “New Insights in the Molecular Biology and Physiology of Streptococcus thermophilus Revealed by Comparative Genomics.” FEMS Microbiology Reviews 29: 435-463. https://doi.org/10.1016/j.fmrre.2005.04.008

[56] Wang, Pei, Peng-Fei Wu, Hua-Jie Wang, Fang Liao, Fang Wang, and Jian-Guo Chen. 2023. “Gut Microbiome-Derived Ammonia Modulates Stress Vulnerability in the Host.” Nature Metabolism 5: 1986-2001. https://doi.org/10.1038/s42255-023-00909-5

[57] Kolling, Glynis L., Martin Wu, Cirle A. Warren, Evelyn Durmaz, Todd R. Klaenhammer, and Richard L. Guerrant. 2014. “Lactic Acid Production by Streptococcus thermophilus Alters Clostridium Difficile Infection and In Vitro Toxin A Production.” Gut Microbes 3: 523-529. https://doi.org/10.4161/gmic.21757

[58] Li, Qing, Wei Hu, Wei-Xin Liu, Liu-Yang Zhao, Dan Huang, Xiao-Dong Liu, Hung Chan, et al. 2021. “Streptococcus thermophilus Inhibits Colorectal Tumorigenesis Through Secreting β-Galactosidase.” Gastroenterology 160: 1179-1193.e14. https://doi.org/10.1053/j.gastro.2020.09.003

[59] He, Yufeng, Qianqian Wang, Xiu Li, Gang Wang, Jianxin Zhao, Hao Zhang, and Wei Chen. 2020. “Lactic Acid Bacteria Alleviate Polycystic Ovarian Syndrome by Regulating Sex Hormone Related Gut Microbiota.” Food & Function 11: 5192-5204. https://doi.org/10.1039/c9fo02554e

[60] Hiipakka, Richard A., Han-Zhong Zhang, Wei Dai, Qing Dai, and Shutsung Liao. 2002. “Structure-Activity Relationships for Inhibition of Human 5α-Reductases by Polyphenols.” Biochemical Pharmacology 63: 1165-1176. https://doi.org/10.1016/s0006-2952(02)00848-1

[61] Wu, Chuyan, Ke Wei, and Zhongli Jiang. 2017. “5α-Reductase Activity in Women With Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis.” Reproductive Biology and Endocrinology 15: 21. https://doi.org/10.1186/s12958-017-0242-9

[62] Magoffin, Denis A. 2006. “Ovarian Enzyme Activities in Women With Polycystic Ovary Syndrome.” Fertility and Sterility 86: S9-S11. https://doi.org/10.1016/j.fertnstert.2006.03.015

[63] Yang, Fan, Chao Chen, Derang Ni, Yubo Yang, Jinhu Tian, Yuanyi Li, Shiguo Chen, Xingqian Ye, and Li Wang. 2023. “Effects of Fermentation on Bioactivity and the Composition of Polyphenols Contained in Polyphenol-Rich Foods: A Review.” Foods 12: 3315. https://doi.org/10.3390/foods12173315

[64] Wang, Mengyao, Lixuan Sang, and Siyu Sun. 2024. “Gut Microbiota and Female Health.” World J Gastroenterol 30: 1655-1662. https://doi.org/10.3748/wjg.v30.i12.1655

[65] Teede, Helena J., Chau Thien Tay, Joop J. E. Laven, Anuja Dokras, Lisa J. Moran, Terhi T. Piltonen, Michael F. Costello, et al 2023. “Recommendations From the 2023 International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome.” Journal of Clinical Endocrinology & Metabolism 108: 2447-2469. https://doi.org/10.1210/clinem/dgad463

[66] Wen, Tao, Penghao Xie, Shengdie Yang, Guoqing Niu, Xiaoyu Liu, Zhexu Ding, Chao Xue, et al. 2022. “ggClusterNet: An R Package for Microbiome Network Analysis and Modularity-Based Multiple Network Layouts.” iMeta 1: e32. https://doi.org/10.1002/imt2.32

[67] Feng, Yinglin, Huimin Zheng, Chunhua Yin, Dong Liang, Siyou Zhang, Jingrui Chen, Feihong Mai, et al. 2024. “β-resorcylic Acid Released by Limosilactobacillus Reuteri Protects Against Cisplatin-Induced Ovarian Toxicity and Infertility.” Cell Reports Medicine 5: 101678. https://doi.org/10.1016/j.xcrm.2024.101678

[68] Marwick, Ben, and Kalimuthu Krishnamoorthy. 2016. “cvequality: Tests for the Equality of Coefficients of Variation From Multiple Groups.” R Package Version 0.2.0. https://doi.org/10.32614/CRAN.package.cvequality

[69] Krishnamoorthy, K., and Meesook Lee. 2013. “Improved Tests for the Equality of Normal Coefficients of Variation.” Computational Statistics 29: 215-232. https://doi.org/10.1007/s00180-013-0445-2

[70] Mangiola, Stefano, Ramyar Molania, Ruining Dong, Maria A. Doyle, and Anthony T. Papenfuss. 2021. “Tidybulk: An R Tidy Framework for Modular Transcriptomic Data Analysis.” Genome Biology 22: 42. https://doi.org/10.1186/s13059-020-02233-7

[71] Love, Michael I., Wolfgang Huber, and Simon Anders. 2014. “Moderated Estimation of Fold Change and Dispersion for RNA-seq Data With DESeq. 2.” Genome Biology 15: 550. https://doi.org/10.1186/s13059-014-0550-8

[72] Wu, Tianzhi, Erqiang Hu, Shuangbin Xu, Meijun Chen, Pingfan Guo, Zehan Dai, Tingze Feng, et al. 2021. “Clusterprofiler 4.0: A Universal Enrichment Tool for Interpreting Omics Data.” Innovation 2: 100141. https://doi.org/10.1016/j.xinn.2021.100141

[73] Slenter, Denise N., Martina Kutmon, Kristina Hanspers, Anders Riutta, Jacob Windsor, Nuno Nunes, Jonathan Mélius, et al. 2017. “WikiPathways: A Multifaceted Pathway Database Bridging Metabolomics to Other Omics Research.” Nucleic Acids Research 46: D661-D667. https://doi.org/10.1093/nar/gkx1064

[74] Wickham, Hadley. 2011. “ggplot2.” WIREs Computational Statistics 3: 180-185. https://doi.org/10.1002/wics.147

[75] Yu, Guangchuang, David K. Smith, Huachen Zhu, Yi Guan, and Tommy Tsan-Yuk Lam. 2017. “Ggtree: An R Package for Visualization and Annotation of Phylogenetic Trees With Their Covariates and Other Associated Data.” Methods in Ecology and Evolution 8: 28-36. https://doi.org/10.1111/2041-210X.12628

[76] Chen, Shifu. 2023. “Ultrafast One-Pass FASTQ Data Preprocessing, Quality Control, and Deduplication Using Fastp.” iMeta 2: e107. https://doi.org/10.1002/imt2.107

[77] Langmead, Ben, and Steven L. Salzberg. 2012. “Fast Gapped-Read Alignment With Bowtie 2.” Nature Methods 9: 357-359. https://doi.org/10.1038/nmeth.1923

[78] DeSantis, T. Z., P. Hugenholtz, N. Larsen, M. Rojas, E. L. Brodie, K. Keller, T. Huber, et al. 2006. “Greengenes, a Chimera-Checked 16S rRNA Gene Database and Workbench Compatible With ARB.” Appl Environ Microbiol 72: 5069-5072. https://doi.org/10.1128/aem.03006-05

[79] Beghini, Francesco, Lauren J. McIver, Aitor Blanco-Míguez, Leonard Dubois, Francesco Asnicar, Sagun Maharjan, Ana Mailyan, et al. 2021. “Integrating Taxonomic, Functional, and Strain-Level Profiling of Diverse Microbial Communities With Biobakery 3.” Elife 10: e65088. https://doi.org/10.7554/eLife.65088

[80] Xu, Shuangbin, Li Zhan, Wenli Tang, Qianwen Wang, Zehan Dai, Lang Zhou, Tingze Feng, et al. 2023. “MicrobiotaProcess: A Comprehensive R Package for Deep Mining Microbiome.” Innovation 4: 100388. https://doi.org/10.1016/j.xinn.2023.100388

[81] Zhang, Yong, Tao Liu, Clifford A. Meyer, Jérôme Eeckhoute, David S. Johnson, Bradley E. Bernstein, Chad Nusbaum, et al. 2008. “Model-Based Analysis of ChIP-Seq (MACS).” Genome Biology 9: R137. https://doi.org/10.1186/gb-2008-9-9-r137

RIGHTS & PERMISSIONS

2025 The Author(s). iMeta published by John Wiley & Sons Australia, Ltd on behalf of iMeta Science.